These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

913 related articles for article (PubMed ID: 27871836)

  • 41. Usefulness of sentinel lymph node mapping using indocyanine green and fluorescent imaging in the diagnosis of lymph node metastasis in endometrial cancer.
    Lee GW; Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    J Obstet Gynaecol; 2021 May; 41(4):605-611. PubMed ID: 32815448
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quality of Care for Cervical and Endometrial Cancer Patients: The Impact of Different Techniques of Sentinel Lymph Node Mapping on Patient Satisfaction.
    Buda A; Elisei F; Palazzi S; De Ponti E; Arosio M; Vecchione F; Dell'Anna T; Cuzzocrea M; Bussi B; Giuliani D; Di Martino G; Crivellaro C
    Ann Surg Oncol; 2016 Sep; 23(9):2975-81. PubMed ID: 27116680
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Indocyanine green fluorescence imaging of lymph nodes during robotic-assisted laparoscopic operation for endometrial cancer. A prospective validation study using a sentinel lymph node surgical algorithm.
    Hagen B; Valla M; Aune G; Ravlo M; Abusland AB; Araya E; Sundset M; Tingulstad S
    Gynecol Oncol; 2016 Dec; 143(3):479-483. PubMed ID: 27776838
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of sentinel Lymph node mapping with different volumes of Indocyanine green in early-stage ENdometrial cancer: the ALIEN study.
    Mauro J; Raimondo D; Di Martino G; Gasparri ML; Restaino S; Neola D; Clivio L; Calidona C; Fruscio R; Vizzielli G; Uccella S; Papadia A; Seracchioli R; Buda A
    Int J Gynecol Cancer; 2024 Jun; 34(6):824-829. PubMed ID: 38336372
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sentinel lymph node intraoperative analysis in endometrial cancer.
    Bellaminutti S; Bonollo M; Gasparri ML; Clivio L; Migliora P; Mazzucchelli L; Papadia A
    J Cancer Res Clin Oncol; 2020 Dec; 146(12):3199-3205. PubMed ID: 32815026
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sentinel node assessment for diagnosis of groin lymph node involvement in vulval cancer.
    Lawrie TA; Patel A; Martin-Hirsch PP; Bryant A; Ratnavelu ND; Naik R; Ralte A
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD010409. PubMed ID: 24970683
    [TBL] [Abstract][Full Text] [Related]  

  • 47. From systematic lymphadenectomy to sentinel lymph node mapping: a review on transitions and current practices in endometrial cancer staging.
    Stämpfli CAL; Papadia A; Mueller MD
    Chin Clin Oncol; 2021 Apr; 10(2):22. PubMed ID: 33951918
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors associated with successful bilateral sentinel lymph node mapping in endometrial cancer.
    Tanner EJ; Sinno AK; Stone RL; Levinson KL; Long KC; Fader AN
    Gynecol Oncol; 2015 Sep; 138(3):542-7. PubMed ID: 26095896
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sentinel lymph node detection in early-stage ovarian cancer: a systematic review and meta-analysis.
    Agusti N; Viveros-Carreño D; Grillo-Ardila C; Izquierdo N; Paredes P; Vidal-Sicart S; Torne A; Díaz-Feijoo B
    Int J Gynecol Cancer; 2023 Oct; 33(10):1493-1501. PubMed ID: 37487662
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Triple tracer (blue dye, indocyanine green, and Tc99) compared to double tracer (indocyanine green and Tc99) for sentinel lymph node detection in endometrial cancer: a prospective study with random assignment.
    Kessous R; How J; Abitbol J; Puzhakkal S; Kogan L; Yasmeen A; Salvador S; Gotlieb WH; Lau S
    Int J Gynecol Cancer; 2019 Sep; 29(7):1121-1125. PubMed ID: 31320490
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The efficiency of a combined injection technique for sentinel lymph node mapping in intermediate-high-risk endometrial cancer.
    Wang Q; Wang B; Wang L; Xue Y; Shan W; Luo X; Wang C; Chen X
    J Surg Oncol; 2021 Dec; 124(8):1551-1560. PubMed ID: 34496048
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sentinel Lymph Node Biopsy in the Treatment of Endometrial Cancer: Why We Fail? Results of a Prospective Multicenter Study on the Factors Associated with Failure of Node Mapping with Indocyanine Green.
    Ianieri MM; Puppo A; Novelli A; Campolo F; Staniscia T; Di Martino G; Piovano E; Bruni F; Roviglione G; Mautone D; Ceccaroni M
    Gynecol Obstet Invest; 2019; 84(4):383-389. PubMed ID: 30661071
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A multicenter noninferior randomized controlled study of sentinel lymph node biopsy alone versus sentinel lymph node biopsy plus lymphadenectomy for patients with stage I endometrial cancer, INSEC trial concept.
    Guo Y; Sun L; Chen X; Wen Q; Shao Z; Tang X; Shi X; Wang J; Zhang Y; Zhu T
    BMC Cancer; 2023 Dec; 23(1):1184. PubMed ID: 38041023
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnostic accuracy of sentinel node biopsy in non-endometrioid, high-grade and/or deep myoinvasive endometrial cancer: A Turkish gynecologic oncology group study (TRSGO-SLN-006).
    Altın D; Taşkın S; Ortaç F; Tokgözoğlu N; Vatansever D; Güler AH; Güngör M; Taşçı T; Beşe T; Turan H; Kahramanoğlu İ; Yalçın İ; Çelik Ç; Demirkıran F; Köse F; Arvas M; Ayhan A; Taşkıran Ç
    Gynecol Oncol; 2022 Mar; 164(3):492-497. PubMed ID: 35033380
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Prospective Study of Sentinel Lymph Node Mapping for Endometrial Cancer: Is It Effective in High-Risk Subtypes?
    Ye L; Li S; Lu W; He Q; Li Y; Li B; Wang X; Yan Q; Wan X
    Oncologist; 2019 Dec; 24(12):e1381-e1387. PubMed ID: 31270269
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sentinel lymph node biopsy with cervical injection of indocyanine green in apparent early-stage endometrial cancer: predictors of unsuccessful mapping.
    Tortorella L; Casarin J; Multinu F; Cappuccio S; McGree ME; Weaver AL; Langstraat CL; Keeney GL; Kumar A; Melis GB; Angioni S; Scambia G; Mariani A; Glaser GE
    Gynecol Oncol; 2019 Oct; 155(1):34-38. PubMed ID: 31402166
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk of empty lymph node packets in sentinel lymph node mapping for endometrial cancer using indocyanine green.
    Thomaier L; Jager L; Stone R; Wethington S; Fader A; Tanner EJ
    Int J Gynecol Cancer; 2019 Mar; 29(3):513-517. PubMed ID: 30833439
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sentinel Node Mapping in Cervical and Endometrial Cancer: Indocyanine Green Versus Other Conventional Dyes-A Meta-Analysis.
    Ruscito I; Gasparri ML; Braicu EI; Bellati F; Raio L; Sehouli J; Mueller MD; Panici PB; Papadia A
    Ann Surg Oncol; 2016 Oct; 23(11):3749-3756. PubMed ID: 27160526
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Indocyanine Green versus Radiotracer with or without Blue Dye for Sentinel Lymph Node Mapping in Stage >IB1 Cervical Cancer (>2 cm).
    Di Martino G; Crivellaro C; De Ponti E; Bussi B; Papadia A; Zapardiel I; Vizza E; Elisei F; Diestro MD; Locatelli L; Gasparri ML; Di Lorenzo P; Mueller M; Buda A
    J Minim Invasive Gynecol; 2017; 24(6):954-959. PubMed ID: 28571944
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Defining the learning curve for successful staging with sentinel lymph node biopsy for endometrial cancer among surgeons at an academic institution.
    Tucker K; Staley SA; Gehrig PA; Soper JT; Boggess JF; Ivanova A; Rossi E
    Int J Gynecol Cancer; 2020 Mar; 30(3):346-351. PubMed ID: 31911534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.